EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC-ND 4.0

Development and Validation of a Capillary Electrophoresis Coupled to Mass Spectrometry Pipeline for Comparable Assessment of the Plasma Peptidome

Lucie Fernandez, Benjamin Breuil, Carine Froment, Mouhamed Seye, Babacar Sylla, Marina Estanco, Adeline Chaubet, Eléonore Delecroix, Karima Chaoui, Jeanne Pierrette Vu, Serban Ardeleanu, Stanislas Faguer und 4 weitere

PROTEOMICS · 2025

DOI: 10.1002/pmic.202400114 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift PROTEOMICS, 2025. Verfasst von Lucie Fernandez und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institut National de la Santé et de la Recherche Médicale (INSERM), U1297, Institute of Cardiovascular and Metabolic Disease, Toulouse, France. Hauptthemen laut MEDLINE: Kidney Failure, Chronic, Peptides, Proteomics, Proteome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although capillary electrophoresis coupled to mass spectrometry (CE‐MS) holds promise for urinary peptide profiling, only a limited number of studies have used CE‐MS to study plasma peptides. Here we describe the establishment of a workflow, including sample preparation, CE‐MS analysis, data processing and normalization optimized for the analysis of plasma peptides. Using 291 plasma samples from 136 patients with end stage kidney failure (including pre‐ and post‐dialysis samples) and 20 patients with chronic kidney disease, we identified and quantified the abundance of 3920 unique plasma peptides. The repeatability and intermediate precision of the analysis were high (with a coefficient of variation of 5% on average for all peptides). Six hundred sixty‐one out of 3920 peptides were sequenced by CE‐MS/MS. These peptide fragments belonged to 135 parent proteins. Using the pipeline, we identified 169 sequenced plasma peptides with different plasma abundance pre‐ and post‐dialysis. These peptides combined in a support vector machine (SVM) classifier successfully discriminated between pre‐ and post‐dialysis samples in a blinded validation cohort of 45 dialysis patients. Enriched peptides post‐dialyses were for the major part associated to inflammation and the coagulation contact systems that may serve as signatures for optimizing dialysis materials. In conclusion, this high‐throughput strategy focuses on the plasma peptidome, an understudied component of the plasma, as a promising area for further exploration. Due to their close proximity to the vascular bed, plasma peptides hold significant potential to serve as reliable biomarkers for systemic complications associated with kidney disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney Failure, ChronicPeptidesProteomicsProteomeMass SpectrometryBlood ProteinsHumansElectrophoresis, CapillaryMaleFemaleMiddle AgedTandem Mass SpectrometryRenal DialysisRenal Insufficiency, ChronicReproducibility of ResultsAged

Stichwörter der Autor:innen

biomarkerscardiovascular diseasechronic kidney diseasepeptidomeplasma

Substanzen

PeptidesProteomeBlood Proteins

Autor:innen und Institutionen

  • Institut National de la Santé et de la Recherche Médicale (INSERM), U1297, Institute of Cardiovascular and Metabolic Disease, Toulouse, France.
  • Université de Toulouse, Toulouse, France.
  • Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III - Paul Sabatier (UT3), Toulouse, France.
  • AURAR Saint Louis Dialysis Center, Saint Louis, La Réunion, France.
  • Département de Néphrologie et Transplantation d'organes, Hôpital Rangueil, Centre Hospitalo-Universitaire de Toulouse, Toulouse, France.

ORCID-Profile: Joost P Schanstra

Zitieren

APA

Fernandez, L., Breuil, B., Froment, C., Seye, M., Sylla, B., Estanco, M., Chaubet, A., Delecroix, E., Chaoui, K., Vu, J. P., Ardeleanu, S., Faguer, S., Burlet-Schiltz, O., Buffin-Meyer, B., Schanstra, J. P., & Klein, J. (2025). Development and Validation of a Capillary Electrophoresis Coupled to Mass Spectrometry Pipeline for Comparable Assessment of the Plasma Peptidome. PROTEOMICS. https://doi.org/10.1002/pmic.202400114

Vancouver

Fernandez L, Breuil B, Froment C, Seye M, Sylla B, Estanco M, et al. Development and Validation of a Capillary Electrophoresis Coupled to Mass Spectrometry Pipeline for Comparable Assessment of the Plasma Peptidome. PROTEOMICS. 2025. doi:10.1002/pmic.202400114

BibTeX
@article{Fernandez2025,
  author = {Fernandez, Lucie and Breuil, Benjamin and Froment, Carine and Seye, Mouhamed and Sylla, Babacar and Estanco, Marina and Chaubet, Adeline and Delecroix, Eléonore and Chaoui, Karima and Vu, Jeanne Pierrette and Ardeleanu, Serban and Faguer, Stanislas and Burlet-Schiltz, Odile and Buffin-Meyer, Bénédicte and Schanstra, Joost P and Klein, Julie},
  title = {Development and Validation of a Capillary Electrophoresis Coupled to Mass Spectrometry Pipeline for Comparable Assessment of the Plasma Peptidome},
  journal = {PROTEOMICS},
  year = {2025},
  doi = {10.1002/pmic.202400114}
}
Kostenlos starten →